Blood-Brain Barrier Disruption after Cardiac Surgery

References

1. 1.↵
   1. Bendszus M,
   2. Reents W,
   3. Franke D,
   4. et al

   . Brain damage after coronary artery bypass grafting. Arch Neurol 2002;59:1090–95

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Restrepo L,
   2. Wityk RJ,
   3. Grega MA,
   4. et al

   . Diffusion- and perfusion-weighted magnetic resonance imaging of the brain before and after coronary artery bypass grafting surgery. Stroke 2002;33:2909–15

   Abstract/FREE Full Text
3. 3.↵
   1. Knipp SC,
   2. Matatko N,
   3. Wilhelm H,
   4. et al

   . Evaluation of brain injury after coronary artery bypass grafting. A prospective study using neuropsychological assessment and diffusion-weighted magnetic resonance imaging. Eur J Cardiothorac Surg 2004;25:791–800

   Abstract/FREE Full Text
4. 4.↵
   1. Djaiani G,
   2. Fedorko L,
   3. Borger M,
   4. et al

   . Mild to moderate atheromatous disease of the thoracic aorta and new ischemic brain lesions after conventional coronary artery bypass graft surgery. Stroke 2004;35:e356–58

   Abstract/FREE Full Text
5. 5.↵
   1. Floyd TF,
   2. Shah PN,
   3. Price CC,
   4. et al

   . Clinically silent cerebral ischemic events after cardiac surgery: their incidence, regional vascular occurrence, and procedural dependence. Ann Thorac Surg 2006;81:2160–66

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Knipp SC,
   2. Matatko N,
   3. Schlamann M,
   4. et al

   . Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: relation to neurocognitive function. Eur J Cardiothorac Surg 2005;28:88–96

   Abstract/FREE Full Text
7. 7.↵
   1. Jeon SB,
   2. Lee JW,
   3. Kim SJ,
   4. et al

   . New cerebral lesions on T2*-weighted gradient-echo imaging after cardiac valve surgery. Cerebrovasc Dis 2010;30:194–99

   CrossRefPubMed
8. 8.↵
   1. Grieco G,
   2. d'Hollosy M,
   3. Culliford AT,
   4. et al

   . Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Methodological strategies and results of a double-blind, placebo-controlled trial of GM1 ganglioside. Stroke 1996;27:858–74

   Abstract/FREE Full Text
9. 9.↵
   1. Rinder C

   . Cellular inflammatory response and clinical outcome in cardiac surgery. Curr Opin Anaesthesiol 2006;19:65–68

   CrossRefPubMed
10. 10.↵
    1. Cavaglia M,
    2. Seshadri SG,
    3. Marchand JE,
    4. et al

    . Increased transcription factor expression and permeability of the blood brain barrier associated with cardiopulmonary bypass in lambs. Ann Thorac Surg 2004;78:1418–25

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Okamura T,
    2. Ishibashi N,
    3. Zurakowski D,
    4. et al

    . Cardiopulmonary bypass increases permeability of the blood-cerebrospinal fluid barrier. Ann Thorac Surg 2010;89:187–94

    CrossRefPubMed
12. 12.↵
    1. Wilkinson ID,
    2. Griffiths PD,
    3. Hoggard N,
    4. et al

    . Unilateral leptomeningeal enhancement after carotid stent insertion detected by magnetic resonance imaging. Stroke 2000;31:848–51

    Abstract/FREE Full Text
13. 13.↵
    1. Dechambre SD,
    2. Duprez T,
    3. Grandin CB,
    4. et al

    . High signal in cerebrospinal fluid mimicking subarachnoid haemorrhage on FLAIR following acute stroke and intravenous contrast medium. Neuroradiology 2000;42:608–11

    CrossRefPubMed
14. 14.↵
    1. Mamourian AC,
    2. Hoopes PJ,
    3. Lewis LD

    . Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation. AJNR Am J Neuroradiol 2000;21:105–11

    Abstract/FREE Full Text
15. 15.↵
    1. Köhrmann M,
    2. Struffert T,
    3. Frenzel T,
    4. et al

    . The hyperintense acute reperfusion marker on fluid-attenuated inversion recovery magnetic resonance imaging is caused by gadolinium in the cerebrospinal fluid. Stroke 2012;43:259–61

    Abstract/FREE Full Text
16. 16.↵
    1. Mathews VP,
    2. Caldemeyer KS,
    3. Lowe MJ,
    4. et al

    . Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology 1999;211:257–63

    CrossRefPubMed
17. 17.↵
    1. Latour LL,
    2. Kang DW,
    3. Ezzeddine MA,
    4. et al

    . Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 2004;56:468–77

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Rozanski M,
    2. Ebinger M,
    3. Schmidt WU,
    4. et al

    . Hyperintense acute reperfusion marker on FLAIR is not associated with early haemorrhagic transformation in the elderly. Eur Radiol 2010;20:2990–96

    CrossRefPubMed
19. 19.↵
    1. Henning EC,
    2. Latour LL,
    3. Hallenbeck JM,
    4. et al

    . Reperfusion-associated hemorrhagic transformation in SHR rats: evidence of symptomatic parenchymal hematoma. Stroke 2008;39:3405–10

    Abstract/FREE Full Text
20. 20.↵
    1. Henning EC,
    2. Latour LL,
    3. Warach S

    . Verification of enhancement of the CSF space, not parenchyma, in acute stroke patients with early blood-brain barrier disruption. J Cereb Blood Flow Metab 2008;28:882–86

    CrossRefPubMed
21. 21.↵
    1. Kidwell CS,
    2. Latour L,
    3. Saver JL,
    4. et al

    . Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke. Cerebrovasc Dis 2008;25:338–43

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Michel E,
    2. Liu H,
    3. Remley KB,
    4. et al

    . Perfusion MR neuroimaging in patients undergoing balloon test occlusion of the internal carotid artery. AJNR Am J Neuroradiol 2001;22:1590–96

    Abstract/FREE Full Text
23. 23.↵
    1. Batra A,
    2. Latour LL,
    3. Ruetzler CA,
    4. et al

    . Increased plasma and tissue MMP levels are associated with BCSFB and BBB disruption evident on post-contrast FLAIR after experimental stroke. J Cereb Blood Flow Metab 2010;30:1188–99

    CrossRefPubMed
24. 24.↵
    1. Warach S,
    2. Latour LL

    . Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 2004;35:2659–61

    Abstract/FREE Full Text
25. 25.↵
    1. Barr TL,
    2. Latour LL,
    3. Lee KY,
    4. et al

    . Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. Stroke 2010;41:e123–28

    Abstract/FREE Full Text
26. 26.↵
    1. Wardlaw JM,
    2. Doubal F,
    3. Armitage P,
    4. et al

    . Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 2009;65:194–202

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Murata Y,
    2. Rosell A,
    3. Scannevin RH,
    4. et al

    . Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke 2008;39:3372–77

    Abstract/FREE Full Text
28. 28.↵
    1. Sood RR,
    2. Taheri S,
    3. Candelario-Jalil E,
    4. et al

    . Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. J Cereb Blood Flow Metab 2008;28:431–38

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Nagel S,
    2. Su Y,
    3. Horstmann S,
    4. et al

    . Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase. Brain Res 2008;1188:198–206

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Trzepacz PT,
    2. Baker RW,
    3. Greenhouse J

    . A symptom rating scale for delirium. Psychiatry Res 1988;23:89–97

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Batra A,
    2. Song SS,
    3. Merino JG,
    4. et al

    . Older patients are at higher risk for blood-brain barrier disruption following treatment with IV-TPA, independent of impaired kidney function. Stroke 2011;42:e253
32. 32.↵
    1. Rosenberg GA,
    2. Estrada EY,
    3. Dencoff JE

    . Matrix metalloproteinases and TIMPS are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998;29:2189–95

    Abstract/FREE Full Text
33. 33.↵
    1. Altinbas A,
    2. van Zandvoort MJ,
    3. van den Berg E,
    4. et al

    . Cognition after carotid endarterectomy or stenting: a randomized comparison. Neurology 2011;77:1084–90

    CrossRef
34. 34.↵
    1. Sheng X,
    2. Thomas A,
    3. Warach S,
    4. et al

    . Acute cortical lesions “disappear” on MRI but are associated with cortical atrophy in stroke patients: implications for brain aging and vascular cognitive impairment. Stroke 2010;41:e14
35. 35.↵
    1. Alvarez-Sabín J,
    2. Delgado P,
    3. Abilleira S,
    4. et al

    . Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke 2004;35:1316–22

    Abstract/FREE Full Text
36. 36.↵
    1. van Harten AE,
    2. Scheeren TW,
    3. Absalom AR

    . A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia. Anaesthesia 2012;67:280–93

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Shlosberg D,
    2. Benifla M,
    3. Kaufer D,
    4. et al

    . Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 2010;6:393–403

    CrossRefPubMed
38. 38.↵
    1. Biancari F,
    2. Mosorin M,
    3. Rasinaho E,
    4. et al

    . Postoperative stroke after off-pump versus on-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007;133:169–73

    CrossRefPubMedWeb of Science
39. 39.↵
    1. van Dijk D,
    2. Spoor M,
    3. Hijman R,
    4. et al

    . Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. JAMA 2007;297:701–08

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Deliganis AV,
    2. Fisher DJ,
    3. Lam AM,
    4. et al

    . Cerebrospinal fluid signal intensity increase on FLAIR MR images in patients under general anesthesia: the role of supplemental O₂. Radiology 2001;218:152–56

    CrossRefPubMed
41. 41.↵
    1. Anzai Y,
    2. Ishikawa M,
    3. Shaw DW,
    4. et al

    . Paramagnetic effect of supplemental oxygen on CSF hyperintensity on fluid-attenuated inversion recovery MR images. AJNR Am J Neuroradiol 2004;25:274–79

    Abstract/FREE Full Text